BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Ring Energy
REI
$349M
| $5.58M | ﹤0.01% |
1,892,335
-21,154
| -1% | -$54K |
|
|
RAIN
3827
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $5.58M | ﹤0.01% |
372,747
+15,159
| +4% | +$259K |
|
|
CALA
3828
DELISTED
Calithera Biosciences, Inc
CALA
| $5.53M | ﹤0.01% |
126,825
-12,980
| -9% | -$560K |
|
|
PLXP
3829
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $5.53M | ﹤0.01% |
286,278
+173,297
| +153% | +$3.03M |
|
|
BGRY
3830
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $5.5M | ﹤0.01% |
782,767
+203,535
| +35% | +$1.74M |
|
3831
Owlet
OWLT
$182M
| $5.49M | ﹤0.01% |
+70,128
| New | +$7.84M |
|
|
LOMA
3832
Loma Negra
LOMA
$1.11B
| $5.49M | ﹤0.01% |
769,321
+20,783
| +3% | +$155K |
|
|
ATTO
3833
DELISTED
Atento S.A.
ATTO
| $5.47M | ﹤0.01% |
193,944
| – | – |
|
3834
Vera Therapeutics
VERA
$2.08B
| $5.45M | ﹤0.01% |
314,037
+313,444
| +52,857% | +$5.6M |
|
|
ENZ
3835
DELISTED
Enzo Biochem, Inc.
ENZ
| $5.42M | ﹤0.01% |
1,532,170
-18,215
| -1% | -$60.8K |
|
3836
Establishment Labs
ESTA
$2.25B
| $5.4M | ﹤0.01% |
75,415
+13,551
| +22% | +$998K |
|
3837
Bain Capital Specialty
BCSF
$821M
| $5.38M | ﹤0.01% |
362,353
+25,502
| +8% | +$388K |
|
3838
SOPHiA GENETICS
SOPH
$649M
| $5.38M | ﹤0.01% |
+306,774
| New | +$5.4M |
|
3839
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $5.37M | ﹤0.01% |
47,870
-1,994
| -4% | -$229K |
|
|
LAC
3840
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $5.36M | ﹤0.01% |
239,836
+237,235
| +9,121% | +$4.17M |
|
|
BBIG
3841
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $5.34M | ﹤0.01% |
61,289
+34,528
| +129% | +$2.33M |
|
3842
China Yuchai International
CYD
$1.71B
| $5.32M | ﹤0.01% |
391,657
-4,591
| -1% | -$66.7K |
|
|
CDR
3843
DELISTED
Cedar Realty Trust, Inc
CDR
| $5.32M | ﹤0.01% |
245,307
-2,212
| -0.9% | -$40K |
|
3844
Neuropace
NPCE
$498M
| $5.29M | ﹤0.01% |
333,974
-521
| -0.2% | -$10.9K |
|
3845
SLR Investment Corp
SLRC
$711M
| $5.29M | ﹤0.01% |
276,486
+33,048
| +14% | +$630K |
|
|
LEVL
3846
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $5.29M | ﹤0.01% |
179,693
-13,005
| -7% | -$358K |
|
3847
Companhia Siderúrgica Nacional
SID
$1.19B
| $5.2M | ﹤0.01% |
987,660
-3,408
| -0.3% | -$25.6K |
|
3848
Xponential Fitness
XPOF
$206M
| $5.18M | ﹤0.01% |
+408,350
| New | +$4.74M |
|
|
CODX
3849
Co-Diagnostics
CODX
$5.49M
| $5.17M | ﹤0.01% |
17,709
+444
| +3% | +$130K |
|
|
SFE
3850
DELISTED
Safeguard Scientifics, Inc.
SFE
| $5.17M | ﹤0.01% |
581,628
+2,756
| +0.5% | +$22.1K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.